These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20694275)

  • 1. Haemophilia, human immunodeficiency virus and human immunodeficiency virus pathogenesis.
    Lederman MM
    Thromb Haemost; 2010 Nov; 104(5):911-4. PubMed ID: 20694275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia.
    Angelotta C; McKoy JM; Fisher MJ; Buffie CG; Barfi K; Ramsey G; Frohlich L; Bennett CL
    Vox Sang; 2007 Aug; 93(2):159-65. PubMed ID: 17683360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral safety of coagulation factor concentrates: memoirs from an insider.
    Mannucci PM
    J Thromb Haemost; 2018 Apr; 16(4):630-633. PubMed ID: 29383815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiologic study of a human immunodeficiency virus 1 outbreak in haemophiliacs B infected through clotting factor 9 after 1990.
    Cho YK; Foley BT; Sung H; Kim YB; Kim JH
    Vox Sang; 2007 Feb; 92(2):113-20. PubMed ID: 17298572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophilia, blood products and HIV infection.
    Lowe GD
    Scott Med J; 1987 Aug; 32(4):109-11. PubMed ID: 3672104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV infection in Norwegian haemophiliacs: the prevalence of antibodies against HIV in haemophiliacs treated with lyophilized cryoprecipitate from volunteer donors.
    Evensen SA; Ulstrup J; Skaug K; Frøland SS; Glomstein A; Rollag H
    Eur J Haematol; 1987 Jul; 39(1):44-8. PubMed ID: 3115823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV and hemophilia.
    Aledort LM; Evatt BL; Lusher JM; Brownstein AP
    J Thromb Haemost; 2007 Mar; 5(3):607-10. PubMed ID: 17319907
    [No Abstract]   [Full Text] [Related]  

  • 8. Th17 cells, HIV and the gut mucosal barrier.
    Dandekar S; George MD; Bäumler AJ
    Curr Opin HIV AIDS; 2010 Mar; 5(2):173-8. PubMed ID: 20543596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus infection in haemophiliacs in Taiwan: the importance of CD4 lymphocyte count in the progression to acquired immunodeficiency syndrome.
    Shen MC; Hu FC; Lin JS; Hsie SW; Hung CC; Chung CY
    Haemophilia; 1998 Mar; 4(2):115-21. PubMed ID: 9873849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GB virus C/hepatitis G virus infection in HIV infected patients with haemophilia despite treatment with virus inactivated clotting factor concentrates.
    Woelfle J; Berg T; Bialek R; Keller KM; Effenberger W; Wagner N
    Arch Dis Child; 1999 May; 80(5):429-32. PubMed ID: 10208947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of the 32-bp CCR-5 deletion on HIV transmission and HIV disease progression in individuals with haemophilia.
    Pasi KJ; Sabin CA; Jenkins PV; Devereux HL; Ononye C; Lee CA
    Br J Haematol; 2000 Oct; 111(1):136-42. PubMed ID: 11091193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort.
    Simmonds P; Beatson D; Cuthbert RJ; Watson H; Reynolds B; Peutherer JF; Parry JV; Ludlam CA; Steel CM
    Lancet; 1991 Nov; 338(8776):1159-63. PubMed ID: 1682589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of HIV in haemophilia.
    Ragni MV
    Haemophilia; 1998 Jul; 4(4):601-9. PubMed ID: 9873801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation.
    Darby SC; Ewart DW; Giangrande PL; Spooner RJ; Rizza CR; Dusheiko GM; Lee CA; Ludlam CA; Preston FE
    Lancet; 1997 Nov; 350(9089):1425-31. PubMed ID: 9371165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological studies in haemophilic children.
    Nicholson NA; Karabus CD; Beatty DW; Becker WB
    S Afr Med J; 1987 May; 71(9):567-9. PubMed ID: 2953077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation.
    Darby SC; Ewart DW; Giangrande PL; Spooner RJ; Rizza CR
    Lancet; 1996 Jun; 347(9015):1573-9. PubMed ID: 8667864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying the source of infection for HIV-infected hemophiliacs in the U.K. from 1979 to 1984.
    Jewell NP
    Stat Med; 2009 May; 28(10):1464-72. PubMed ID: 19235711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain.
    Batlle J; Villar A; Liras A; Alonso C; Altisent C; Brito D; Moreno M; Lucía F; Sedano C; Prieto M; Calvente N; Aznar JA; Jiménez V; Soriano V; Martorell JR; Iruín G; Bergua JM; Aguilar C
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):333-40. PubMed ID: 18600079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS and haemophilia.
    Bloom AL
    Biomed Pharmacother; 1985; 39(7):355-65. PubMed ID: 3938297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VIII, HIV and AIDS in haemophiliacs: an analysis of their relationship.
    Papadopulos-Eleopulos E; Turner VF; Papadimitriou JM; Causer D
    Genetica; 1995; 95(1-3):25-50. PubMed ID: 7538088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.